GB201312499D0 - Therapeutic compounds - Google Patents
Therapeutic compoundsInfo
- Publication number
- GB201312499D0 GB201312499D0 GBGB1312499.5A GB201312499A GB201312499D0 GB 201312499 D0 GB201312499 D0 GB 201312499D0 GB 201312499 A GB201312499 A GB 201312499A GB 201312499 D0 GB201312499 D0 GB 201312499D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic compounds
- therapeutic
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1312499.5A GB201312499D0 (en) | 2013-07-12 | 2013-07-12 | Therapeutic compounds |
PCT/GB2014/052143 WO2015004485A1 (en) | 2013-07-12 | 2014-07-14 | Therapeutic compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1312499.5A GB201312499D0 (en) | 2013-07-12 | 2013-07-12 | Therapeutic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201312499D0 true GB201312499D0 (en) | 2013-08-28 |
Family
ID=49081184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1312499.5A Ceased GB201312499D0 (en) | 2013-07-12 | 2013-07-12 | Therapeutic compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201312499D0 (en) |
WO (1) | WO2015004485A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11930815B1 (en) | 2023-08-29 | 2024-03-19 | King Faisal University | 3,3′-(piperazine-1,4-diyl)bis(1-(naphthalen-2-yloxy)propan-2-ol) as insecticidal agent |
US11998013B1 (en) | 2023-09-01 | 2024-06-04 | King Faisal University | 1-(morpholin-4-yl)-3-(naphthalen-2-yloxy)propan-2-ol as an eco-friendly insecticidal agent against spodoptera littoralis (boisd.) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5614523A (en) * | 1995-01-17 | 1997-03-25 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
EP1077973A2 (en) * | 1998-05-14 | 2001-02-28 | Egis Gyogyszergyar Rt. | Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient |
US20070111970A1 (en) * | 2005-10-13 | 2007-05-17 | Antonio Cruz | Inositol compounds and uses of same in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, desposition, accumulation or persistence |
US20100279997A1 (en) * | 2009-05-04 | 2010-11-04 | Lindsay Burns Barbier | Analgesic that binds filamin a |
KR101476379B1 (en) * | 2011-11-30 | 2014-12-29 | 한국과학기술연구원 | Derivatives of 1-Phenoxy propan-2-ol and pharmaceutical composition containing the same |
JP6417324B2 (en) * | 2012-07-13 | 2018-11-07 | ペイン セラピューティクス インコーポレイテッド | Methods for inhibiting tau phosphorylation |
-
2013
- 2013-07-12 GB GBGB1312499.5A patent/GB201312499D0/en not_active Ceased
-
2014
- 2014-07-14 WO PCT/GB2014/052143 patent/WO2015004485A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2015004485A1 (en) | 2015-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201321746D0 (en) | Therapeutic agents | |
GB201321743D0 (en) | Therapeutic agents | |
GB201321738D0 (en) | Therapeutic Agents | |
GB201321736D0 (en) | Therapeutic agents | |
GB201321729D0 (en) | Therapeutic agents | |
GB201321733D0 (en) | Therapeutic agents | |
AP2015008713A0 (en) | Tetrahydropyrrolothiazine compounds | |
GB201321728D0 (en) | Therapeutic agents | |
GB201321739D0 (en) | Therapeutic agents | |
GB201321730D0 (en) | Therapeutic agents | |
GB201321741D0 (en) | Therapeutic agents | |
GB201321740D0 (en) | Therapeutic agents | |
GB201321732D0 (en) | Therapeutic agents | |
GB201321734D0 (en) | Therapeutic Agents | |
GB201321737D0 (en) | Therapeutic Agents | |
GB201321744D0 (en) | Therapeutic agents | |
GB201321742D0 (en) | Therapeutic agents | |
GB201321735D0 (en) | Therapeutic Agents | |
GB201321745D0 (en) | Therapeutic agents | |
GB201308440D0 (en) | Therapeutic | |
GB201321748D0 (en) | Therapeutic agents | |
GB201321731D0 (en) | Therapeutic agents | |
AP2015008699A0 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
GB201321749D0 (en) | Therapeutic agents | |
GB201310755D0 (en) | Therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |